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Protocol
AbstrACt
Introduction Liver disease is the third most common 
cause of premature mortality in the UK. Liver failure 
accelerates frailty, resulting in skeletal muscle atrophy, 
functional decline and an associated risk of liver transplant 
waiting list mortality. However, there is limited research 
investigating the impact of exercise on patient outcomes 
pre and post liver transplantation. The waitlist period for 
patients listed for liver transplantation provides a unique 
opportunity to provide and assess interventions such as 
prehabilitation.
Methods and analysis This study is a phase I 
observational study evaluating the feasibility of conducting 
a randomised control trial (RCT) investigating the use 
of a home-based exercise programme (HBEP) in the 
management of patients awaiting liver transplantation. 
Twenty eligible patients will be randomly selected from 
the Queen Elizabeth University Hospital Birmingham liver 
transplant waiting list. Participants will be provided with 
an individually tailored 12-week HBEP, including step 
targets and resistance exercises. Activity trackers and 
patient diaries will be provided to support data collection. 
For the initial 6 weeks, telephone support will be given 
to discuss compliance with the study intervention, 
achievement of weekly targets, and to address any queries 
or concerns regarding the intervention. During weeks 
6–12, participants will continue the intervention without 
telephone support to evaluate longer term adherence to 
the study intervention. On completing the intervention, all 
participants will be invited to engage in a focus group to 
discuss their experiences and the feasibility of an RCT.
Ethics and dissemination The protocol is approved by 
the National Research Ethics Service Committee North 
West - Greater Manchester East and Health Research 
Authority (REC reference: 17/NW/0120). Recruitment into 
the study started in April 2017 and ended in July 2017. 
Follow-up of participants is ongoing and due to finish 
by the end of 2017. The findings of this study will be 
disseminated through peer-reviewed publications and 
international presentations. In addition, the protocol will be 
placed on the British Liver Trust website for public access.
trial registration number NCT02949505; Pre-results.
IntroduCtIon 
Liver disease is the third most common cause 
of premature mortality in the UK.1 Currently, 
a liver transplant is the only cure for 
end-stage liver disease.2 The existing shortage 
of donor organs highlights the importance 
of being able to accurately identify those 
individuals who will benefit the most from 
transplantation.
Frailty is defined as the biological syndrome 
of decreased reserve and resistance to 
stressors, which cause vulnerability to adverse 
outcomes.3 Liver failure accelerates this 
process, resulting in skeletal muscle atrophy 
(sarcopaenia), reduced functional capacity 
and an associated increased risk of liver trans-
plant waiting list mortality.4
Evidence suggests that a subgroup of 
patients with end-stage liver disease who 
have low functional capacity, defined as an 
anaerobic threshold of less than 9 mL/kg/
min, have lower survival rates post-transplan-
tation5 and predict a longer hospital stay.6 
Despite these findings, current management 
of end-stage liver disease tends to focus on 
preventing and treating complications (ie, 
variceal haemorrhage, ascites), rather than 
prospective strategies to improve functional 
capacity.
Research in non-end-stage liver disease 
populations has demonstrated the potential 
role of preoperative exercise programmes, 
strengths and limitations of this study
 ► This is the first study to investigate a home-based 
exercise programme in patients with end-stage liver 
disease and listed for liver transplantation.
 ► This is an extensive clinical evaluation of functional 
capacity and quality of life in a high-risk group 
of patients in whom there is a pressing need for 
optimisation prior to transplantation.
 ► This is a pilot study of small sample size, but with 
the aim and design focusing on the feasibility of a 
randomised control trial of prehabilitation in patients 
awaiting liver transplantation.
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‘known as prehabilitation’, in optimising patients’ func-
tional capacity prior to abdominal surgery and reducing 
postoperative complications.7 8 Furthermore, exercise 
training has been shown to improve functional capacity 
and quality of life in a wide variety of chronic diseases.9–11 
The time period for patients while active on the liver 
transplant waiting list provides a unique opportunity to 
provide physical interventions, such as prehabilitation. 
This could potentially have a significant effect on short-
term, medium-term and long-term outcomes at a rela-
tively low cost.12
Recently, studies have demonstrated significant 
improvement in functional capacity following delivery 
of an exercise programme in patients with all causes 
of liver disease.13–17 Furthermore, significant improve-
ments in muscle mass14 15 and EuroQol Group EQ-visual 
analogue of self-perceived health status15 were shown. 
Although all studies suggest exercise is a safe interven-
tion in this patient population, three of the five studies 
excluded patients with end-stage cirrhosis.14–16 In view of 
this, as well as small participant numbers in each study, 
the safety of this intervention cannot be certain. More-
over, all studies were undertaken with weekly, directly 
supervised exercise sessions only. The seven UK National 
Health Service (NHS) liver transplant centres cover a 
vast geographical area; therefore, twice-weekly visits by 
patients to their nearest transplant centres are unlikely to 
be feasible. Interventions that can be conducted local to 
the patient’s homes or indeed in the patient’s own homes 
need to be evaluated in a randomised control trial (RCT).
Before an RCT can be conducted, a feasibility study is 
required to determine if a larger trial is possible, and if 
so outline the optimal design features. Therefore, the 
aim of this study is to conduct a single-centre feasibility 
trial of a novel home-based exercise programme (HBEP) 
in patients with end-stage liver disease awaiting liver 
transplantation.
MEthods And AnAlysIs
study design overview
The proposed feasibility trial is a single-arm, single-
centre study of an HBEP for patients listed for liver 
transplantation.
Patients recruited to the study at the Queen Eliza-
beth University Hospital Birmingham (QEUHB) UK 
liver transplant unit will be treated with a 12-week HBEP 
(figure 1). Functional capacity, health-related quality of 
life, anxiety and depression, anthropometry, and adverse 
events will be assessed at baseline, 6 weeks and 12 weeks 
after the study intervention is commenced.
On completion of the HBEP intervention, participants 
will be invited to attend a process evaluation focus group. 
The purpose of the focus group is to identify attitudes, 
motivators and barriers to the study intervention, as well 
as to reflect on the usefulness/acceptability of the study 
Figure 1 Study design overview.
box Process evaluation focus group research questions
1. What motivated the participants to adhere to the study 
intervention?
2. Did the participants identify any barriers to completing the study 
intervention?
3. How useful did the participants find the accelerometers?
4.  How useful did the participants find the weekly telephone 
support?
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materials and equipment. Data will be collected and used 
to address the research questions outlined in the box.
Ethical and regulatory approval
The National Research Ethics Service, Health Research 
Authority and the University Hospital Birmingham (UHB)
Research and Dissemination group will be informed of 
any protocol modifications within 7 days. All participants 
will provide informed written consent.
sample and selection
Twenty eligible patients will be selected from the QEUHB 
liver transplantation waiting list using a stratified random 
sampling method, completed by MJA. Subgroups will 
include four patients from each of the following disease 
types: alcoholic liver disease, non-alcoholic fatty liver 
disease, autoimmune liver disease, genetic liver disease 
and viral hepatitis. This is to ensure that various forms of 
liver disease will be represented in the study. Patients will 
be eligible to be included in the study if they meet the 
following criteria:
Inclusion criteria
 ► Meet the UK liver transplant criteria for listing.18
 ► Accepted on the liver transplant waiting list for a 
primary transplant.
 ► Adults ≥18 years.
Exclusion criteria
 ► Significant cardiovascular instability including a 
recent myocardial infarction (MI), recent cerebro-
vascular accident (CVA) and/or a recent unstable 
cardiac arrhythmia.
 ► Unstable encephalopathy—open to interpretation by 
the chief investigator.
 ► Neither patient or next-of-kin non-English-speaking.
 ► Inpatient at the time of screening.
 ► Refusal or lacks capacity to give informed consent.
Once deemed eligible, patients will be sent a letter of 
invitation to be involved in the study, along with a partic-
ipant information sheet. Patients will be contacted by 
telephone 5–7 days after the letters are sent by the chief 
investigator or a nominated member of the research 
team. If participants are willing to take part, an appoint-
ment will be arranged within 6 weeks, when patients will 
be able to provide informed written consent.
MEthods
Patients on the QEUHB liver transplant waiting list 
routinely attend outpatient clinics on six-weekly basis. All 
study visits will be incorporated into their routine clin-
ical follow-up. On attendance to clinic (baseline study 
visit), participants will complete baseline assessments of 
functional capacity, anthropometry and questionnaires to 
assess quality of life and anxiety and depression. The study 
intervention will be completed for 6 weeks with weekly tele-
phone support, including a telephone questionnaire (see 
online supplementary appendix 1). On return to clinic at 
week 6 (study visit 2), functional capacity, quality of life 
and anxiety/depression scores will be reassessed. For the 
remaining 6 weeks of the study, participants will continue 
with the HBEP, but without telephone support. This is to 
assess the carryover effect of information provided and 
assess the ability of the participants to continue the HBEP 
independently while on the waiting list. On return to 
clinic at 12 weeks (study visit 3), all participants will be 
reassessed in terms of functional capacity, quality of life 
and anxiety scores. If a participant is unable to participate 
in exercise due to illness for a week or number of weeks, 
then intermittent participation will be permitted. Periods 
of illness and intermittent participation will be recorded 
on the case report form (CRF) and accounted for in the 
data analysis.
Intervention: hbEP
Participants will be provided with a 6-week HBEP including 
daily step targets and functional resistance-based exercises 
(figure 2). Participants will be provided with an acceler-
ometer (COOSA Heart Rate Monitor) to aid tracking of 
their daily steps and activity levels. In addition, partici-
pants will be asked to record their activity in a diary to aid 
self-reporting at the weekly telephone contact.
Daily step programme
During the first week, participants will be asked to 
monitor their daily step count via their accelerom-
eter. Following weekly telephone contact, participants 
will be advised to increase their daily step count by 
200–500 steps each day every week depending on the 
level of function and achievement of step target of the 
previous week.
Functional resistance exercise sessions
During the initial assessment patients will be taught func-
tional resistance exercises to complete at home (figure 2). 
Information provided will be followed up with an exercise 
worksheet as well as a video to aid patient understanding 
and adherence. Exercises will be regressed if the partici-
pant is unable to complete any of the techniques demon-
strated in figure 2. For example, a step or bed will be used 
for hand positioning in the rock press and bear crawl 
exercises. The public and patient involvement group 
advised to keep exercise sessions short to aid compliance. 
Therefore, sessions will be 20–25 min for each individual, 
but the difficulty of the session will be split into five levels 
as described in table 1. Participants will be advised to 
complete the level most suitable for them depending on 
their baseline functional capacity scores. Participants will 
be asked to achieve a work rate of 12–13 on the Borg Rate 
of Perceived Exertion (RPE) score (6–20 scale).19 An RPE 
score of 12–13 has been shown to correlate with anaer-
obic threshold in healthy individuals20 and will therefore 
guide the participants to work to a training level that will 
elicit change in functional capacity. Participants will be 
advised to stop exercising if they reached above 15 on the 
RPE score or if they feel a change in symptoms, including 
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dizziness, light-headedness and chest pain. Participants 
will be advised to progress to each level depending on 
their RPE scores and results of the telephone health call 
questionnaire. At the 6-week assessment, participants will 
be advised to progress to a different level of exercise and 
to continue to increase their step count by 200–500 steps 
per day, per week depending on the results of their func-
tional capacity scores. Additional exercises, as shown in 
levels 4 and 5 in table 1, will be taught if needed.
Telephone health call
During the first 6 weeks of the study intervention, partici-
pants will receive one 20 min telephone call weekly from 
the chief investigator or a nominated member of the 
research team. The purpose of the telephone call is to 
provide support and guidance with the study intervention 
and address the following areas:
 ► Compliance to the study intervention.
 ► Achievement of weekly preagreed step count and 
functional resistance exercise level.
 ► Step target for the following week.
 ► Queries or concerns regarding the intervention.
 ► Incidence of any adverse events.
After 6 weeks of the HBEP study intervention, partic-
ipants will continue with the intervention without 
telephone support. This aims to assess longer term adher-
ence to the study intervention without weekly telephone 
support.
Process evaluation focus group
Within 6 weeks of completing the 12-week study interven-
tion, all participants will be invited to attend one of two 
focus groups. The chief investigator, along with a member 
of the research team, will conduct two focus groups 
aiming to (1) explore the thoughts/experiences of the 
participants regarding the study process, and (2) explore 
acceptability of the exercise programme and support 
provided. All participants will be invited to capture the 
range of participant experiences.
outcome measures
Primary outcome
The primary outcome of the study is feasibility whereby 
the decision to proceed to an RCT will be made on the 
following criteria:
1. No serious adverse events (defined as grade 3/4) di-
rectly related to the HBEP.
2. >66% of the active transplant waiting list for prima-
ry grafts must meet the eligibility criteria to achieve 
timely recruitment and representation of the co-
hort.
3. >90% recruitment to target number of participants 
(n=20) during the allotted study time period to 
achieve timely recruitment and assess willingness of 
patients to participate.
4. >66% compliance with the step count (including 
ranges) while active on the transplant waiting list.
5. >66% compliance with resistance exercises while ac-
tive on the transplant waiting list.
6. Of those who undergo initial assessment, >66% com-
plete 6 weeks of HBEP.
Feedback will be documented from those partici-
pants who are approached but who refuse to consent or 
Table 1 Levels of difficulty for each exercise session
Level Exercises Work to rest timings Number of circuits Total session time (min)
1 Frog squat
Rock press
Lunge
Bear crawl
20 s of each exercise
40 s rest
5 20
2 Frog squat
Rock press
Lunge
Bear crawl
30 s of each exercise
30 s rest
5 20
3 Frog squat
Rock press
Lunge
Bear crawl
40 s of each exercise
20 s rest
5 20
4 Frog squat
Rock press
Lunge
Bear crawl
Side bear crawl
40 s of each exercise
20 s rest
4 20
5 Frog squat
Rock press
Lunge
Bear crawl
Side bear crawl
Kick sit
40 s of each exercise
20 s rest
4 24
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withdraw from the study, on the understanding that this 
feedback will be optional.
Candidate primary outcomes
The following candidate outcomes will be assessed at 
baseline (pre-HBEP), and after 6 and 12 weeks of the 
HBEP. Feasibility will be determined according to the 
acceptability and usefulness of these outcome measures, 
as well as time and resources needed to collect data.
Anthropometry
At each study visit body mass index, hand grip strength 
(kg) (Cranlea Human Performance Digital Hand Grip 
Dynamometer), mid-arm circumference (cm) and triceps 
skinfold (mm) (Holtain Tanner/Whitehouse Skinfold 
Caliper) will be assessed. These assessments are currently 
completed as part of standard care by the QEUHB liver 
dietetics team and will be used in the study to ensure 
control of variables and inform the researchers of any 
change in nutrition.
Incremental Shuttle Walk Test
The Incremental Shuttle Walk Test (ISWT) is a stan-
dardised, externally paced, incremental field-walking 
test that evaluates maximal exercise capacity. The patient 
is progressively stressed to a symptom-limited maximal 
performance by walking at different speeds around a 
10 m course, which is dictated by an audio signal. It is a 
reliable21 and valid measure that has been used in a wide 
range of chronic diseases,22–24 as well as a predictor of 
mortality postabdominal surgery.25
Short Performance Battery Test
The Short Performance Battery Test is a physical func-
tional tool that can identify disability and predict mortality 
through assessment of gait speed, balance and repeated 
chair stands. It is a valid tool used within a population of 
patients with liver cirrhosis. A score of less than 9 has been 
associated with a 45% increase in waiting list mortality in 
patients listed for liver transplantation, independent of 
the Model for End-Stage Liver Disease (MELD) score.4
EurolQol-5D (EQ-5D) (V.2.1)
The EQ-5D (V.2.1) is a reliable and validated tool used 
in a wide range of health conditions and treatments. It 
provides information on health status, which will be used 
to help evaluate the clinical and economic value of the 
study intervention.26
Hospital Anxiety and Depression Score
The Hospital Anxiety and Depression Score is a reliable 
and valid tool for assessing anxiety and depression in 
medical patients.27 It will be used to identify if there is 
a need to include psychological support in future larger 
research projects. Participants will be advised on the 
participant information sheet that the purpose of the 
study is not to address any anxiety or depression concerns, 
and if they feel this is a concern they should contact their 
general practitioners.
Telephone questionnaire
This will be completed weekly throughout the first 6 
weeks of the study intervention. The telephone question-
naire provides a standardised framework for assessing the 
participant’s weekly progress and identifying any areas of 
concern. Furthermore, the answers will provide guided 
goal setting for the following week.
other outcomes
Disease severity
To understand the relationship between the severity 
of liver disease and functional capacity at baseline, 
and possibly inform the need for stratification in the 
future RCT, the Child-Turcotte-Pugh, MELD and the 
UK Model for End Stage Liver Disease will be reported. 
These scores will be used to compare the study sample 
selected with the entire waiting list to ensure there is a 
representative balance of disease severity in the study. 
In addition, these scores will be calculated at 6 and 
12 weeks to inform future hypothesis development for 
the future RCT.
Number and reason for dropouts
All registered dropouts will be recorded according to their 
reason, including1 (1) withdrawal of consent,  (2) liver 
transplantation, (3) acute decompensation leading to 
incapacity to follow the study intervention or (4) death. 
This will provide valuable information when planning 
recruitment for the RCT.
dAtA AnAlysIs PlAn
All quantitative data will be entered into a purposefully 
designed secure access database and exported to SPSS 
(V.24) for statistical analysis. Feasibility decision rules 
and primary candidate outcomes will be analysed and 
presented using descriptive statistics.
Adverse events reported by telephone or in person will 
be descriptively reported in terms of frequency (%). To 
determine compliance with the intervention, the number 
of days when participants achieved their step count and 
completed the functional resistance exercises will be 
reported as categorical variables on a week-by-week basis 
(weeks 1–5).
Two focus groups will be conducted with three thematic 
components: (1) barriers to the intervention, (2) facili-
tators of adherence and (3) level of support received, 
although, where appropriate, sufficient scope will be given 
to explore novel themes. Two members of the research 
team will conduct the focus group. Each session will be 
digitally recorded, transcribed verbatim and uploaded 
into NVivo V.10 software to aid organisation and anal-
ysis of data. NVivo will be used to store data transcripts, 
and as a means by which codes could be highlighted and 
collated based on the themes described above, as well as 
to explore any new emerging themes.
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AdvErsE EvEnts And AnAlysIs
An adverse event (AE) would be unlikely in this study due 
to the extensive investigations the patients have undergone 
prior to being listed for liver transplantation. However, the 
reporting period for AE will start at initial screening and 
continue until the end of the second focus group. Serious 
adverse events (SAEs) will be reported until 30 days post 
each participant’s liver transplant. All SAEs and adverse 
reactions will be evaluated and recorded using the National 
Cancer Institute’s common terminology criteria for AEs 
(V.4.0, 2010) and reported to the principal investigator. All 
SAEs will be reported to the sponsor’s research and devel-
opment department via the SAE form in the CRF. Only 
those events classified as probable or definitely related will 
be reported to the Research Ethics Committee.
storAgE of dAtA
All data for an individual participant will be collected by 
the principal investigator or their delegated nominees 
and recorded in the CRF. Participant identification on 
the CRF will be through their unique participant study 
number, which will be allocated at the time of consider-
ation for the study. Data will be collected from the time 
the patient is considered for entry into the study through 
to 30 days after they receive their liver transplant. All clin-
ical data will be stored as per NHS regulations and held 
on the UK National Transplant Database.
Data from the CRF will be entered into a secure pass-
word-protected database held on a University Hospitals 
Birmingham Trust computer. Due care will be taken to 
ensure data safety and integrity, and compliance with 
the Data Protection Act 1998. All essential documen-
tation and trial records will be stored in conformance 
with the applicable regulatory requirements, and access 
to stored information will be restricted to authorised 
personnel. Coded research data will be stored for 5 years 
anonymously under the property of University Hospitals 
Birmingham in keeping with good clinical practice.
CAsE rEPort forM
CRFs will include baseline/follow-up functional capacity, 
anthropometry and questionnaire scores to capture 
changes in outcomes. Other CRFs incorporated in the 
electronic database will include medical history, eligi-
bility screening, date of transplant, donor organ and 
operation data, length of Intensive Care Unit(ICU) stay, 
30-day outcome post-transplant, safety monitoring, AE 
reporting, study treatment adherence and attendance to 
focus groups.
sPonsorshIP, IndEMnIty And MonItorIng
The QEUHB will act as the sponsor through the duration 
of the study. As sponsor, the QEUHB will be responsible 
for the general conduct of the study and indemnify the 
study centre against any claims arising from any negligent 
act or omission by the hospital, in fulfilling the sponsor 
role in respect to the study.
Contact name of trial sponsor: Dr Chris Counsell.
Contact information of trial sponsor:  chris. counsell@ 
uhb. nhs. uk.
dIsCussIon
This is the first feasibility trial to investigate an HBEP in 
patients listed for liver transplantation. To date 46 patients 
have been randomly screened for eligibility, of whom 32 
are eligible and 26 have agreed to participate in the trial.
Figure 2 Functional resistance exercises: (A) lunge, (B) 
rock press, (C) frog squat, (D) bear crawl, (E) side bear crawl 
and (F) kick sit.
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safety
Few small studies have investigated exercise therapy 
in patients with chronic liver disease.13–16 Each study 
reported the safe use of exercise therapy with no AEs 
described. However, participant numbers were small 
(n≤24), and three of the four studies included patients 
with only mild liver disease, who are not as high risk as 
patients with end-stage liver disease. Furthermore, exer-
cise was supervised by a health professional ensuring that 
participants exercised within safe training zones and were 
able to guide participants when to stop. To ensure safe 
delivery of exercise therapy in this study, education will 
be given to participants regarding RPE with clear colour-
coded training zones. Furthermore, participants will have 
the contact numbers of the physiotherapists working on 
the study and will be advised to inform them if they expe-
rience any AE. This will also be automatically checked 
at the weekly telephone contact. To minimise the risk 
of AEs, the design of the exercise programme was based 
on well-documented training models delivered to other 
patients with chronic cardiovascular and respiratory 
disease in terms of number of sessions per week, length 
of exercise programme (6–12 weeks) and intensity.28 29
Although this study includes participants with end-stage 
liver disease, certain medical conditions will be excluded 
from the study, including cardiovascular instability and 
unstable encephalopathy, to minimise the risk of an SAE. 
Furthermore, unstable encephalopathy may affect the 
participant’s ability to consistently and adequately follow 
the exercise programme. This would affect the analysis of 
feasibility, as well as put unnecessary demand on the main 
carer to support the patient through the process.
Challenges in study design
There are currently no validated outcome measures 
to assess change in functional capacity in patients with 
end-stage liver disease. The ISWT will be used in this 
study because it is a recognised measure of maximal 
exercise capacity and has been shown to correlate well 
with volume oxygen (VO2) peak when compared with 
the gold standard cardiopulmonary exercise test.22 It has 
been previously used to measure change in functional 
capacity in other chronic disease types such as respiratory 
and cardiovascular diseases.23 24 Moreover, the ISWT has 
been shown to predict postsurgical morbidity in patients 
undergoing abdominal surgery.30
In view of a home-based set-up, it is important to 
promote adherence and compliance to the exercise 
programme. Although it is understood that patients 
listed for liver transplantation have a lower quality of life, 
compared with healthy individuals, it is not understood 
what the motivational influences of this patient popu-
lation are. To promote adherence to the programme, a 
self-reported diary and an accelerometer will be given 
to each participant to provide daily visual feedback and 
empower responsibility for their daily and weekly goals. 
Additionally, following demonstration of the functional 
resistance exercises at their initial assessment, participants 
will be provided with written and pictorial instructions, 
as well as a DVD of all of the exercises with front and 
side views including verbal instruction from an exercise 
trainer. At the end of the study, each participant will be 
invited to attend a focus group to feedback on their expe-
rience of the study, with particular reference to the level 
of support they receive, the clarity of the programme and 
motivational influences.
Due to the large geographical area the QEUHB liver 
unit covers, participants have to travel up to 300 miles 
per clinic appointment. It was, therefore, felt that 
limiting participant visits would facilitate recruitment and 
adherence to the study and reduce participant burden. 
Predominantly, patients on the liver transplant waiting list 
are reviewed on a six-weekly basis. Baseline assessments 
will be timed with their prearranged clinical appointment 
so that 6-week and 12-week follow-up will coincide with 
ongoing clinical appointments.
The HBEP was designed to use movements, which 
would challenge the cardiorespiratory system, but also 
encourage movement through multiple planes of motion 
to improve stability, flexibility and balance. Patients with 
end-stage liver disease vary in age, function and exercise 
experience. Exercises were chosen, along with appro-
priate progression and regressions, in order to adapt to 
individual needs. Additionally, five levels of intensity will 
be available based on increasing work time and reducing 
rest time. These will ensure participants exercise at a level 
consistent with their exercise capacity, but have room for 
progression over the 12-week period.
future rCt considerations
NHS England aims to encourage and support healthier 
behaviours through the use of NHS accredited health 
apps.31 In the current study, participants will record their 
activity in a written diary and verbally report back at their 
weekly telephone support. In a larger RCT the use of 
accelerometers with live data collection would be consid-
ered. This would aim to empower patients to proactively 
monitor their activity and work towards patient-centred 
goals. Furthermore, the physiotherapist could monitor 
adherence and progression of the exercise programme 
on a daily basis. This would give better indication to toler-
ance to the exercise programme and would enable specific 
exercise intensity advice and avoid participant reporter 
bias. However, it is currently unknown if all patients have 
access to smart phones for live data to be recorded on 
an app. Likewise, virtual clinics could be used instead of 
telephone support. This would provide a more interac-
tive experience for the patient. The physiotherapist could 
review exercise techniques and demonstrate alternatives 
as required.
This phase I trial is critical to understanding potential 
recruitment rates, withdrawal rates, patients undergoing 
transplantation or death in the study period and HBEP 
completion rates in order to accurately power the number 
of participants required for the future RCT.
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To the best of our knowledge this is the first study to inves-
tigate an HBEP in patients listed for liver transplantation. 
The enrolment of participants to the study was completed 
in July 2017 and the final results are expected by May 
2018.
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